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Background 
There is wide variation in survival rates from out-of-hospital cardiac arrest (OHCA) and overall survival 
remains poor. There is expert consensus that early reperfusion therapy in ST-elevation (STE) reduces 
mortality. The management of patients without STE however is controversial.  
 
Methods 
The MINAP database is a national registry of all hospital admissions in England and Wales treated as 
acute coronary syndrome (ACS). We examined temporal trends, over a 5-year period, of OHCAs 
identified by the Myocardial Ischaemia National Audit Project (MINAP) registry, admitted to hospital and 
treated as ACS, the interventional management of these patients and clinical outcomes.  
 
Results  
410,462 patients were admitted to hospital in England and Wales with ACS. Of these, 9,421 presented 
with OHCA (2.30%). There was an increase in OHCA cases as a proportion of ACS between 2009 and 
2013 (2.74% in 2013 versus 1.79% in 2009; Ptrend<0.001). The rate of coronary angiography + 
percutaneous coronary intervention (CA+PCI) increased in ACS patients presenting with OHCA (66.3% 
in 2013 (884/1,334) versus 54.9% in 2009 (876/1,595); Ptrend<0.001). Time-varying cox-proportional 
hazards model demonstrated CA±PCI (in patients with and without STE) was associated with reduced 
mortality before (HR=0.35, 95% CI: 0.20 to 0.60; P<0.05) and after (HR=0.36, 95% CI: 0.25 to 0.50; 
P<0.001) 30 days. Predictors of favourable outcome were synonymous with the selection criteria for 
patients undergoing CA±PCI.  
 
Conclusions 
This observational study showed that selection for CA±PCI was associated with reduced mortality in 
OHCA patients diagnosed with ACS. These data support the need for a randomized controlled trial. 
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Background 
Out-of-hospital cardiac arrest (OHCA) is a global public health issue. Each year there are approximately 
28,000 emergency medical services (EMS)–treated OHCA in England and approximately 330,000 EMS-
attended OHCA in the United States.1,2 There is wide variation in survival rates from OHCA and overall 
survival remains poor, with a reported average of 7%.1 The adoption of systematic approaches to 
cardiopulmonary resuscitation may improve long term survival from OHCA.3,4 Post-resuscitation care in-
hospital including targeted temperature management and treatment of the underlying cause through 
coronary reperfusion is thought to further improve this survival in patients with acute coronary syndromes 
(ACS).5 It is difficult to conclude which of the components of post-arrest care is essential, given the 
observational nature of studies. Coronary artery disease is responsible for > 70% of OHCA of presumed 
cardiac cause, with an acute occlusion demonstrated in 50% of consecutive patients taken immediately 
to coronary angiography.6 There is expert consensus that early reperfusion therapy in ST-elevation (STE) 
reduces mortality.7,8 The management of patients without STE however is controversial, with an emphasis 
placed on prior rule out of non-coronary causes.8 Randomized data are lacking and the benefit of early 
reperfusion therapy remains debated. This has led to a variable uptake of such a strategy amongst the 
interventional cardiology community. The Myocardial Ischaemia National Audit Project (MINAP) database 
is a non-commercially funded national registry of all hospital admissions treated as ACS in England and 
Wales, established to examine the quality of management of hospitals providing acute cardiac care.9 The 
strengths of this registry include its size and national reach. This database selectively captures OHCAs 
that are admitted to hospital with a final diagnosis of ACS and does not encompass all OHCA admissions 
to hospital. Therefore the aim of this study was to examine the temporal trends, over a 5-year period, of 
OHCAs identified by the MINAP registry, admitted to hospital and treated as ACS, the interventional 
management of these patients and clinical outcomes.  
 
Methods 
The MINAP registry consists of 123 core data-points, including cardiovascular risk factors, occurrence of 
cardiac arrest, post-resuscitation therapies including coronary angiography and PCI, and outcomes 
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including in-hospital mortality and neurological outcome; these data-points have been published 
previously.10 Of the 123 separate fields, 49 data sets were extracted and examined (Section 1, 
Supplementary Material). These clinical audit data are a valuable resource and missing values are 
inevitable when large volumes of data are collected and have the potential to bias or reduce the efficiency 
of statistical estimators if they are not treated appropriately. Thus we performed multiple imputations to 
deal with these missing data. Patients are identified at individual hospital level and data entry, performed 
by trained personnel, undergoes annual validation through re-audit. MINAP has approval from the Patient 
Information Advisory Group to use patient identifiable information without individual patient consent. 
MINAP approved this current registry-based project and data analyses were performed at King’s College 
London, St Thomas’ Hospital, UK with the support of London School of Hygiene and Tropical Medicine 
Clinical Trials Unit, UK.  
 
Study Population and Outcomes Reported 
For the purposes of this study, fully anonymized data were retrospectively extracted from the MINAP 
dataset of hospitals in England and Wales accepting admissions between January 2009 and July 2013. 
ACS was categorized as ST-Elevation myocardial infarction (STEMI) or Non-STEMI based on biomarker 
and electrocardiographic criteria. OHCA was defined as cardiac arrest before arrival at hospital. 
Procedural intervention was classed as no coronary angiogram, coronary angiogram alone and coronary 
angiogram + PCI. In-hospital mortality is defined as patient death in-hospital. Life status is tracked by 
MINAP through linkage with the Office of National Statistics using the unique National Health Service 
identifier (number), thus represents in-hospital mortality and subsequent mortality following discharge. 
 
Statistical Analysis 
Categorical data were presented as counts and percentages, and comparison between groups performed 
using chi-square test; numerical data were presented as mean ± SD, and analysis performed using one-
way ANOVA. The temporal trends in identification of OHCA, followed by distribution of baseline 
characteristics (male gender, presence of STE, previous MI, previous angina, hypertension, 
hypercholesterolemia, peripheral vascular disease, cerebrovascular disease, chronic renal failure, heart 
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failure, smoking history, diabetes, previous PCI, previous coronary artery bypass graft surgery (CABG), 
family history, presenting rhythm of pulseless ventricular tachycardia/ventricular fibrillation (VT/VF) and 
age>75), the rate of procedural intervention, in-hospital mortality and good neurological outcome (defined 
as cerebral performance category 1 or 2 at discharge) of the ACS cohort presenting with OHCA were 
examined. For trend analysis year-on-year we used the Cochran-Armitage test for trend to test for linear 
relationships between categorical variables. To determine independent predictors for in-hospital mortality 
and the odds of undergoing procedural intervention (CA±PCI), multivariable adjusted logistic regression 
models were used to generate odds ratios. To limit the number of variables for the final multivariable 
models, stepwise regression was performed using the above covariates (entry criteria P<0.05, exit criteria 
P>0.1); significant variables were used in the final model.  Final model selection was performed using 
multiple imputation (Fully Conditional Specification, SPSS v24.0 (IBM Corp.©)) to impute missing data on 
baseline covariates by chained equations to create 5 multiply imputed datasets to maximise statistical 
power (missing values and multiple imputation methodology is reported in Section 2, Supplementary 
material). The variables used in the final model of the odds of undergoing CA±PCI were: gender, STE, 
previous MI, previous angina, hypertension, hypercholesterolemia, peripheral vascular disease, 
cerebrovascular disease, chronic renal failure, heart failure, smoking history, diabetes, previous PCI, 
previous CABG, family history, VT/VF and age>75. The variables used in the final model for in-hospital 
mortality were as for the previous model with the addition of CA±PCI. No significant co-linearity was 
demonstrated. Due to the large proportion of missing data, complete case analysis was performed in 
parallel, these results were compared with those of multiply imputed data to increase the robustness of 
our conclusions (Section 3, Supplementary material). Time to event analysis was performed using 
Kaplan-Meier curves, Cox proportional hazard analyses model was performed to generate (i) time-varying 
hazard ratio for <30 days and >30 days and (ii) time-varying exposure to coronary angiography (to 
account for survival bias) using time-varying covariate of transition time to coronary angiogram. All p 
values were two-sided with a significance threshold P<0.05. Statistical analysis was performed using 
SPSS v24.0 (IBM Corp.©). 
 
Results 
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Trends in Incidence of ACS Presenting as OHCA 
Figure 1 details case identification. From January 2009 to July 2013 we identified 410,462 patients 
admitted to hospital in England and Wales with a final discharge diagnosis of troponin positive ACS. Over 
the 5-year period, 385,509 did not experience cardiac arrest and 24,953 experienced cardiac arrest. Of 
the 24,953 cardiac arrest patients, 9,421 of these patients were identified as out-of-hospital cardiac arrest 
(OHCA). The overall proportion of ACS patients presenting with OHCA (9,421) relative to the overall 
cohort of patients diagnosed with ACS (410,462) was 2.3%. This proportion increased yearly from 2009 
to 2013 (1.8% (1,595/89,380) in 2009, 2.0% (1,835/91,087) in 2010, 2.4% (2,142/90,559) in 2011, 2.8% 
(2,515/90,705) in 2012 to 2.7% (1,334/48,731) in 2013; Ptrend<0.001), Section 4, Supplementary material.  
 
Baseline Characteristics of Identified Cases of OHCA  
Table 1 depicts the changes in baseline demographics from 2009 to 2013 of the study cohort under 
question of patients identified in-hospital with a discharge diagnosis of ACS who presented with OHCA 
(n=9,421) (Figure 1). In the overall cohort of ACS patients presenting with OHCA, the prevalence of known 
underlying ischemic heart disease (previous angina (20.4% (326/1595) in 2009 versus 15.8% (211/1334) 
in 2013; Ptrend<0.001), previous acute myocardial infarction (21.8% (348/1595) in 2009 versus 17.4% 
(232/1334) in 2013; Ptrend<0.05) and previous CABG (7.3% (116/1595) in 2009 versus 5.5% (73/1334) in 
2013; Ptrend<0.05) and risk factors for coronary artery disease (hypercholesterolemia (28.8% (459/1595) 
in 2009 versus 25.0% (333/1334) in 2013; Ptrend<0.05), smoking history (64.5% (1028/1595) in 2009 
versus 60.6% (809/1334) in 2013; Ptrend<0.05) and positive family history (25.5% (407/1595) in 2009 
versus 23.1% (308/1334) in 2013; Ptrend<0.001)) significantly decreased. There was no significant change 
in patients presenting with pulseless VT/VF (88.9% (1418/1595) in 2009 versus 86.9% (1159/1334) in 
2013; Ptrend=0.06) (Section 4, Supplementary Material). An increase in male gender (74.8% (1193/1595) 
in 2009 versus 77.7% (1037/1334) in 2013; Ptrend<0.05) and STE on the post-resuscitation ECG (62.6% 
(999/1595) versus in 2009 versus 65.4% (872/1334) in 2013; Ptrend<0.05) was seen. In this overall cohort 
of 9,421 OHCA patients identified in-hospital with a discharge diagnosis of ACS, male gender (75.9%, 
7,148/9,421) with presenting rhythm of VT/VF (88.2%, 8,313/9,421) and ST elevation (STE) on the post-
resuscitation ECG (65.0%, 6124/9,421) predominated. 
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Trends in Coronary Angiography in Identified Cases of OHCA 
Of the 9,421 patients identified in-hospital with a discharge diagnosis of ACS that presented with OHCA: 
18.0% (1,699/9,421) did not undergo a coronary procedure; 20.8% (1,964/9,421) underwent coronary 
angiography (CA) alone and 61.1% (5,758/9,421) underwent CA+PCI. Within this OHCA cohort of ACS 
patients, over the 5-year period, CA+PCI increased from 54.9% (876/1,595) in 2009 to 66.3% (884/1,334) 
in 2013 (Ptrend<0.001); conversely, CA alone decreased from 22.0% (351/1,595) in 2009 to 20.0% 
(267/1,334) in 2013 (Ptrend<0.001) and the proportion of patients who did not undergo coronary procedure 
also decreased from 23.1% (368/1,595) in 2009 to 13.7% (183/1,344) in 2013 (Ptrend<0.001) (annual 
trends are available in (Section 5, Supplementary Material). The median number of days to angiogram 
was 0.3 days (IQR 0 to 1.3 days) and the maximum time to angiogram was 365 days. Of the overall cohort 
of ACS patients presenting with OHCA, 9.4% (882/9,421) of patients died prior to coronary angiography.  
 
We then examined the temporal trends in baseline characteristics of patients selected to undergo CA±PCI 
within the OHCA subgroup of ACS patients (CA±PCI; 7,722/9,421) over the 5-year period (Table 2). From 
2009 to 2013, in the cohort of patients documented as having undergone CA±PCI, there was a significant 
increase in the proportion of male patients (76.0% (933/1,227) in 2009 versus 79.1% in 2013 (910/1,151); 
Ptrend<0.05) undergoing CA±PCI. There was a significant decrease in the prevalence of cardiovascular 
risk factors in this cohort: including a family history of cardiovascular disease (27.8% in 2009 (341/1,227) 
versus 24.7% in 2013 (284/1,151); Ptrend<0.001); previous myocardial infarction (19.7% (242/1,227) in 
2009 versus 16.0% (184/1,151) in 2013; Ptrend<0.05); history of angina (18.6% (228/1,227) in 2009 versus 
14.7% (169/1,151) in 2013; Ptrend<0.05); hypercholesterolemia (29.3% (360/1,227) in 2009 versus 25.1% 
(289/1,151) in 2013; Ptrend<0.05)  and smoking history (65.4% (803/1,227) in 2009 versus 61.6% 
(709/1,151) in 2013; Ptrend<0.05). The proportion of patients undergoing CA±PCI with VT/VF as the 
presenting rhythm also decreased (91.2% (1,119/1,227) in 2009 versus 89.5% (1,030/1,151) in 2013; 
Ptrend<0.05). From the 5-year cohort of ACS patients presenting with OHCA (9,421), an overall comparison 
of baseline characteristics was made between the groups of patients selected to undergo CA alone 
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(1,964/9,421), CA+PCI (5,758/9,421) and patients who did not undergo a coronary angiogram 
(1,699/9,421); these are presented in Table 3.  
 
Multivariable logistic regression analysis of the patients identified in-hospital with a discharge diagnosis 
of ACS who presented with OHCA (n=9,421) was performed to determine the odds of undergoing (i) 
CA±PCI and (ii) CA+PCI in this cohort, Table 4. If STE was present, there was an eight fold increased 
probability of receiving CA+PCI (adjusted OR 8.34, 95% CI 7.00 to 9.94; P <0.05). A presenting rhythm 
of VT/VF (adjusted OR 2.16, 95% CI 1.29 to 3.63; P <0.05) or previous PCI (adjusted OR 1.88, 95% CI 
1.24 to 2.85; P <0.05) was associated with a two fold increased probability of receiving CA+PCI. Patients 
had a significantly higher probability of receiving CA+PCI in the presence of cardiovascular risk factors 
including hypercholesterolemia (adjusted OR 1.31, 95% CI 1.04 to 1.66; P <0.05) and smoking history 
(adjusted OR 1.45, 95% CI 1.20 to 1.76; P <0.05). Conversely, those with previous coronary artery bypass 
grafting (adjusted OR 0.46, 95% CI 0.35 to 0.61; P <0.05) and heart failure (adjusted OR 0.69, 95% CI 
0.49 to 0.98; P <0.05) were less likely to undergo a coronary procedure, Table 4. 
 
Trends in Clinical Outcomes 
Length of stay was also examined in the overall cohort of ACS patients presenting with OHCA. Median 
length of stay was 5 days (IQR 2 to 11) and the maximum length of stay was 388 days. In patients 
identified with a discharge diagnosis of ACS who presented with OHCA (n=9,421), overall in-hospital 
mortality was 29.2% (2,753/9,421). In patients identified with a discharge diagnosis of ACS who presented 
with OHCA (n=9,421), we compared clinical outcomes in patients who underwent a coronary procedure 
with those who did not. This was further divided into no coronary angiogram (1,699/9,421), CA alone 
(1,964/9,421) and CA+PCI (5,758/9,421). Overall, in patients who underwent CA+PCI, in-hospital death 
was significantly lower than in patients who underwent CA alone (21.8% CA+PCI 1,258/5,758, versus 
37.3% CA alone, 734/1,964; P<0.001) and significantly lower than in patients who underwent no coronary 
procedure (21.8% CA+PCI, 1,258/5,758 versus 44.8% 761/1,699, no coronary procedure; P<0.001). Over 
the 5-year period, trend analysis demonstrated a significant increase in in-hospital mortality from 27.8% 
(443/1595) in 2009 to 31.0% (414/1334) in 2013 in the overall cohort of OHCA ACS patients (n=9,421). 
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In patients who underwent CA+PCI (n=5,758), trend analysis showed a slight but significant increase in 
in-hospital mortality over the 5-year period from 20.2% (177/876) in 2009 to 22.6% (200/884) in 2013 
(Ptrend <0.001). However, this increase in mortality was significantly less than the increase in mortality in 
the CA alone cohort (33.6% (118/351) in 2009 versus 44.3% (117/267) in 2013; P<0.001) and in patients 
who underwent no coronary procedure (40.2% (148/368) in 2009 versus 53% (97/183) in 2013; P<0.001).  
 
Multivariable logistic regression analysis of the patients identified in-hospital with a discharge diagnosis 
of ACS who presented with OHCA was performed to determine predictors of in-hospital mortality 
(n=9,421). These were: older age (>75 years; OR 1.59; 95% CI 1.34 to 1.89; P<0.001) and the presence 
of pre-existing comorbidities including diabetes (OR 2.04; 95% CI 1.75 to 2.36; P<0.001), heart failure 
(OR 1.84; 95% CI 1.36 to 2.47; P<0.001), cerebrovascular disease (OR 1.63; 95% CI 1.29 to 2.07; 
P<0.001), chronic renal failure (OR 1.66; 95% CI 1.04 to 1.78; P<0.05) and peripheral vascular disease 
(OR 1.70; 95% CI 1.26 to 2.30; P<0.001) (Table 5). Conversely, the risk of in-hospital death was 
decreased if the patient presented with VT/VF (OR 0.21; 95% CI 0.17 to 0.26; P<0.001), male sex (OR 
0.78; 95% CI 0.68 to 0.89; P<0.001) and had risk factors for coronary disease including 
hypercholesterolemia (OR 0.69; 95% CI 0.59 to 0.81; P<0.001), smoking history (OR 0.72; 95% CI 0.61 
to 0.84; P<0.001) and family history (OR 0.37; 95% CI 0.32 to 0.44; P<0.001). CA+PCI was also 
associated with decreased risk of in-hospital mortality in the STE cohort (OR 0.58; 95% CI 0.36 to 0.96; 
P<0.05) but not the non-STE cohort (Table 5). 
 
In patients identified with a discharge diagnosis of ACS who presented with OHCA we compared 
neurological outcomes between patients who underwent a coronary procedure with those who did not 
(n=9,421). This was further divided into no procedure (1,699), CA alone (1,964) and CA+PCI (5,758). In 
patients who underwent CA+PCI, good neurological outcome was significantly higher than in patients 
who underwent CA alone (61.6% CA+PCI, 3546/5758 versus 41.4% CA alone, 814/1964; P<0.001) and 
significantly higher than in patients who underwent no coronary procedure (61.6% CA+PCI, 3546/5758 
versus 35.6% no procedure, 604/1,699; P<0.001). Trend analysis over the 5-year period showed a 
significant decrease in the proportion of patients with good neurological outcome in the overall OHCA 
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ACS cohort from 54.2% (864/1595) in 2009 to 51.3% (685/1334) in 2013 (P=0.05). In patients who 
underwent CA+PCI, trend analysis showed no significant change in good neurological outcome over the 
5-year period from 2009 to 2013 (63.4% in 2009 (555/876) versus 61.0%% (539/884) in 2013; Ptrend 
=0.07). However, in both the CA alone (45.6% (160/351) in 2009 versus 34.3% (92/268) in 2013; P<0.001) 
and no coronary angiogram (40.2% (148/368) in 2009 versus 29.5% (54/183) in 2013; P<0.001) cohorts, 
a significant decrease in good neurological outcome was seen over the 5-year period. Figure 2 
demonstrates temporal trends in good neurological outcome in the overall cohort of OHCA ACS patients, 
those who underwent CA+PCI and the rate of coronary intervention. 
 
In the OHCA cohort of ACS patients the association of coronary procedure with life status (survival both 
in-hospital and following discharge) was examined (Figure 3). Cox-proportional hazards model was used 
to generate time varying hazard ratios for short term and long term follow up. This demonstrated 
significant difference in survival between those selected to undergo any coronary procedure (CA±PCI) 
versus no (coronary) procedure both before 30 days (HR=0.35, 95% CI: 0.20 to 0.60; P<0.05) and after 
30 days (HR=0.36, 95% CI: 0.25 to 0.50; P<0.001). This was further supported by Cox Proportional 
Hazards model analysis with time-varying exposure to coronary angiography (HR 0.43, 95% CI: 0.29 to 
0.57; P<0.05).   
 
Discussion 
In this large, 5-year, retrospective observational study, examining patients identified in-hospital with a 
final diagnosis of ACS, with a specific focus on those presenting with OHCA, the main findings were as 
follows: 1) the proportion of ACS patients identified as presenting with OHCA increased over the 5-year 
period. 2) An increase in the rate of CA+PCI was demonstrated. 3) Patient selection for CA±PCI favored 
male patients, under 75, with STE on the post-resuscitation ECG with a presenting rhythm of VT/VF. 4) 
A significant increase in CA±PCI in the STE patients was seen over time. 5) Overall in-hospital mortality 
was significantly lower and neurological outcome better in patients selected to undergo CA+PCI from the 
ACS cohort presenting with OHCA (both STE and non-STE patients). 6) Over the 5-year period the rate 
of good neurological outcome in the CA+PCI cohort remained unchanged. 
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The MINAP registry was established with the intention of capturing all patients admitted to hospital, 
diagnosed with and treated as acute coronary syndrome. MINAP is a hospital-based ACS registry 
completed by Cardiology personnel, thus will not capture all patients resuscitated from cardiac arrest and 
admitted to hospital. As part of a focus on improving care, the Department of Health for England 
introduced survival from cardiac arrest as part of the Ambulance Service National Quality Indicators from 
2011 onwards. This provides data from 2011 to 2013, on the number of patients surviving to hospital with 
return of spontaneous circulation (ROSC) (5,910 in 2011, 7,662 in 2012 and 8,033 in 2013).12 Comparison 
of these data with MINAP data would suggest that MINAP captures approximately one third of 
resuscitated cardiac arrest patients and admitted to hospital. Interestingly, the number of resuscitated 
cardiac arrests admitted to hospital increased yearly according to Ambulance Service data. Our study 
also demonstrated an increase in the number of OHCA patients diagnosed and treated as ACS over the 
5-year period. This could, in part, reflect a shift in post cardiac arrest management, with a greater 
percentage of patients admitted and surviving to hospital with OHCA who are investigated for and treated 
as ACS. However, this could also be attributable to improved case ascertainment in both pre-hospital and 
hospital-based audit systems.  
 
Of patients identified in-hospital with a discharge diagnosis of ACS who presented with OHCA, the 
proportion of OHCA patients presenting with VT/VF per year within the in-hospital ACS cohort, remained 
unchanged. Comparison of these data with Ambulance Service National Quality Indicators demonstrate 
a similar picture, with the proportion of resuscitated cardiac arrests delivered to hospital with a presenting 
rhythm of VT/VF also remaining unchanged. This is despite the overall decrease in the observed 
incidence of VT/VF arrest out-of-hospital. This could be explained by pre-hospital factors, which include 
the decision by the ambulance crews to perform resuscitation and a more favourable outcome in this 
cohort, thus patients surviving to hospital with ROSC. It could also partially be explained by selection bias 
whereby a cardiac arrest with presenting rhythm of VT/VF is thought more likely to be ischemic in origin, 
and thus more likely to be treated and diagnosed with ACS, and thus entered into the MINAP database. 
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Over the 5-year period, distribution of baseline characteristics of the OHCA patients captured within the 
MINAP registry and therefore diagnosed with ACS broadened to include patients without traditional risk 
factors for coronary disease. This and the observed increase in the proportion of OHCA patients receiving 
coronary intervention could reflect a more pro-active approach both in England and internationally to post-
arrest care during this period, with increased recognition and emphasis placed on the benefits of specialist 
cardiac care to manage ensuing cardiovascular dysfunction and treatment of the potential underlying 
cause through reperfusion. 13 This is in addition to the national increase in the use of PCI as the preferred 
reperfusion strategy.14 
 
This study identified well-established predictors of survival and good neurological outcome in OHCA 
including VT/VF as the presenting rhythm. This has been shown in numerous observational studies.6,15,16 
Our study also showed that CA+PCI was associated with reduced in-hospital mortality following OHCA 
in patients with STE. CA+PCI was also associated with good neurological outcome and improved long-
term survival. However, this study also showed that predictors of good outcome were synonymous with 
the selection criteria for patients undergoing CA±PCI, suggesting a degree of selection bias for coronary 
angiography towards patients believed to have characteristics associated with a more favorable outcome.  
 
Over the 5-year period, in-hospital mortality increased in the OHCA cohort of ACS patients. However, the 
overall in-hospital mortality of those presenting with OHCA in the MINAP registry was shown to be much 
lower than the Ambulance Service National Quality Indicators would suggest, which is indicative of the 
selective nature of the data, with MINAP only capturing a proportion of all resuscitated cardiac arrests 
admitted to hospital. In OHCA patients who underwent CA+PCI, there was a slight but significant increase 
in in-hospital mortality, despite an increase in CA±PCI. This likely reflects a broadening of selection 
criteria for CAPCI extending to higher risk patients.  
 
The observational nature of these data makes it impossible to derive conclusions about causality. The 
data for CA±PCI in the non-STE OHCA cohort are conflicting. Although non-STE patients in this study 
appeared to fare better with CA±PCI, they remain an extremely heterogeneous cohort, with multiple 
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possible causes for arrest including non-cardiac causes, chronic coronary artery disease and scar-
induced arrhythmia. The non-STE patients in the MINAP registry were a select group, with a confirmed 
diagnosis of ACS, entered into the database retrospectively, thus these findings cannot be transferable 
to all non-STE patients. However, these data would suggest that regardless of post-resuscitation ECG 
findings, patients with ACS as the cause of OHCA could benefit from CA±PCI. In the absence of STE 
following cardiac arrest, the ECG is less reliable in guiding diagnosis and a focus is placed on 
hemodynamic status and possible preceding symptoms prior to arrest. Recently published ESC 
guidelines recommend rule out of non-coronary causes prior to coronary angiography.8 In the absence 
of convincing randomized data we are yet to determine the best post-arrest strategy for these patients. 
Further investigation in the form of a randomized trial of routine invasive angiography and 
revascularization, where appropriate following OHCA is necessary. The key factor here is to identify which 
patients benefit from an early invasive strategy. The coordination of this however, is complex, and close 
interaction is necessary pre-hospital between centers and emergency services and internally between 
the emergency department, Cardiologists, and the critical care unit. Several planned randomized control 
trials including Early Coronary Angiography Versus Delayed Coronary Angiography NCT02387398 and 
A Randomized tRial of Expedited transfer to a cardiac arrest center for non-ST elevation out of hospital 
cardiac arrest; ISRCTN 96585404 will address the optimal post-arrest pathway for these patients and if 
coronary angiography should be routinely performed in all patients with resuscitated arrest of presumed 
cardiac cause.17 
 
Limitations 
There are a number of limitations in this study that are inherent to retrospective database analysis that 
preclude conclusions with regard to causality. There was a large proportion of missing data, analyses of 
individuals with only full datasets can introduce bias thus multiple imputation analysis was performed. 
Multiple imputation works on the assumption that data are missing at random. Despite consistency in 
results in comparison with complete case analysis, and inclusion of a large number of variables in the MI 
model, we cannot confirm if the systematic differences between the missing values and the observed 
values can be explained by differences in observed data thus may be subject to bias. Therefore the results 
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of this study must be considered hypothesis generating, thus supporting the need for a randomized 
controlled trial in this cohort.   
 
The MINAP database only captures patients with a discharge diagnosis of ACS, which is at most one 
third of resuscitated cardiac arrests admitted to hospital, thus conclusions are not transferrable to the 
entire OHCA population. Furthermore, we cannot compare outcomes between patients with OHCA of 
presumed cardiac cause who received acute cardiac care and those who did not. Due to the lack of 
randomized data, selection for coronary intervention is subjective and we therefore cannot account for 
why individual patients were or were not chosen for this management strategy. This study did not include 
differentiation of outcome by centre; this would have been informative and could be predictive of outcome 
and also of missing values. 
 
Conclusions 
In this MINAP registry there was an increase in the proportion of OHCA cases treated as ACS over the 
5-year period. The rate of CA+PCI increased and was associated with improved survival compared to 
cohorts not selected for this management strategy; however, as selection criteria broadened to include 
patients with additional comorbidities, outcomes declined. The future challenges are to identify those 
patients who will benefit from such a strategy. These data support the need for a randomized controlled 
trial in this patient cohort. 
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Figures 
 
 
 
 
Figure 1. Patient flow diagram and study design. Data were extracted for the time period January 2009 to 
July 2013. Patients were identified in-hospital. All patients with a final discharge diagnosis of acute coronary 
syndrome complicated by out-of-hospital cardiac arrest were included in the final analysis. Abbreviations: 
ACS acute coronary syndrome, OHCA out-of-hospital cardiac arrest, CA coronary angiogram, PCI 
percutaneous coronary intervention 
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Figure 2 The temporal trends in good neurological outcome of the overall OHCA cohort (black) and the 
cohort of coronary angiogram + percutaneous coronary intervention (PCI) (gray), trends in procedural rate 
of coronary angiogram + PCI is also shown (pattern). 
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Figure 3 Survival curves according to coronary angiogram ± PCI (black) and no coronary angiogram 
(gray). Cox-proportional hazards model was used to calculate time-varying hazard ratios. Survival 
represents life status, which includes survival both in-hospital and following discharge. Abbreviations: 
CA coronary angiogram, PCI percutaneous coronary intervention. 
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Baseline Characteristic 
Year of Admission 
 
2009 2010 2011 2012 2013† P value 
Age over 75 391/1595 24.5% 422/1835 23.0% 524/2142 24.5% 625/2515 24.9% 304/1334 22.8% 0.880 
Sex (Male) 1193/1595 74.8% 1369/1835 74.6% 1596/2142 74.5% 1952/2515 77.6% 1037/1334 77.7% <0.05* 
ST-Elevation 999/1595 62.6% 1205/1835 65.7% 1352/2142 63.1% 1696/2515 67.4% 872/1334 65.4% <0.05* 
Previous AMI  348/1595 21.8% 364/1835 19.8% 436/2142 20.4% 483/2515 19.2% 232/1334 17.4% <0.05* 
Previous Angina  326/1595 20.4% 365/1835 19.9% 392/2142 18.3% 394/2515 15.7% 211/1334 15.8% <0.001* 
Hypertension  661/1595 41.4% 768/1835 41.9% 891/2142 41.6% 1046/2515 41.6% 542/1334 40.6% 0.820 
Hypercholesterolemia  459/1595 28.8% 531/1835 28.9% 584/2142 27.3% 670/2515 26.6% 333/1334 25.0% <0.05* 
Peripheral Vascular Disease 46/1595 2.9% 59/1835 3.2% 97/2142 4.5% 94/2515 3.7% 51/1334 3.8% 0.180 
Cerebrovascular Disease 111/1595 7.0% 129/1835 7.0% 152/2142 7.1% 208/2515 8.3% 86/1334 6.4% 0.729 
Chronic Renal Failure  65/1595 4.1% 74/1835 4.0% 87/2142 4.1% 114/2515 4.5% 62/1334 4.6% 0.638 
Heart Failure  92/1595 5.8% 92/1835 5.0% 122/2142 5.7% 144/2515 5.7% 66/1334 4.9% 0.756 
Smoker  1028/1595 64.5% 1160/1835 63.2% 1350/2142 63.0% 1563/2515 62.1% 809/1334 60.6% <0.05* 
Diabetes  188/1595 11.8% 260/1835 14.2% 306/2142 14.3% 382/2515 15.2% 172/1334 12.9% 0.234 
Previous PCI  134/1595 8.4% 143/1835 7.8% 161/2142 7.5% 201/2515 8.0% 99/1334 7.4% 0.339 
Previous CABG  116/1595 7.3% 103/1835 5.6% 112/2142 5.2% 140/2515 5.6% 73/1334 5.5% <0.05* 
Family History  407/1595 25.5% 460/1835 25.1% 548/2142 25.6% 544/2515 21.6% 308/1334 23.1% <0.001* 
Pulseless VT/VF 1418/1595 88.9% 1656/1835 90.2% 1861/2142 86.9% 2218/2515 88.2% 1159/1334 86.9% 0.061 
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Table 1 Annual trends in baseline characteristics, including the cardiovascular risk factors, of the 9,421 patients with troponin 
positive acute coronary syndrome (ACS) presenting as out-of-hospital cardiac arrest (OHCA) over the 5-year period. Data are 
displayed per year, as counts n/N and percentages (%), where n is the number of patients documented as having the presence 
of a baseline characteristic, N is the total number of ACS patients in that year documented as OHCA and % is the proportion 
(2009 N=1595, 2010 N=1835, 2011 N=2142, 2012 N=2515, 2013 N=1334). * Indicates unadjusted P<0.05. †Numerical data only 
available from January to July 2013. Abbreviations in order of appearance: AMI acute myocardial infarction, PCI percutaneous 
coronary intervention, CABG coronary artery bypass graft surgery, VT/VF pulseless ventricular tachycardia/ventricular fibrillation. 
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Baseline Characteristic 
(CA±PCI) 
Year of Admission  
2009 2010 2011 2012 2013† P value 
Age over 75 266/1227 18.4% 301/1468 20.5% 381/1738 21.9% 472/2138 22.0% 239/1151 20.8% 0.724 
Sex (Male) 933/1227 76.0% 1124/1468 76.6% 1323/1738 76.1% 1692/2138 79.1% 910/1151 79.1% <0.05* 
ST-Elevation 832/1227 67.8% 1041/1468 71.0% 1191/1738 68.5% 1539/2138 72.0% 797/1151 69.2% 0.355 
Previous AMI 242/1227 19.7% 262/1468 17.9% 328/1738 18.9% 377/2138 17.6% 184/1151 16.0% <0.05* 
Previous Angina 228/1227 18.6% 259/1468 17.7% 295/1738 17.0% 304/2138 14.2% 169/1151 14.7% <0.05* 
Hypertension 503/1227 41.0% 621/1468 42.3% 710/1738 40.9% 877/2138 41.0% 458/1151 39.8% 0.576 
Hypercholesterolemia 360/1227 29.3% 433/1468 29.5% 483/1738 27.8% 580/2138 27.1% 289/1151 25.1% <0.05* 
Peripheral Vascular Disease 32/1227 2.6% 44/1468 3.0% 74/1738 4.3% 79/2138 3.7% 42/1151 3.6% 0.125 
Cerebrovascular Disease 74/1227 6.0% 88/1468 6.0% 106/1738 6.1% 159/2138 7.4% 63/1151 5.5% 0.806 
Chronic Renal Failure 40/1227 3.3% 46/1468 3.1% 58/1738 3.3% 80/2138 3.7% 45/1151 3.9% 0.593 
Heart Failure 61/1227 5.0% 60/1468 4.1% 89/1738 5.1% 110/2138 5.1% 49/1151 4.3% 0.602 
Smoker 803/1227 65.4% 946/1468 64.5% 1117/1738 64.3% 1353/2138 63.3% 709/1151 61.6% <0.05* 
Diabetes 136/1227 11.1% 201/1468 13.7% 247/1738 14.2% 323/2138 15.1% 137/1151 11.9% 0.124 
Previous PCI 108/1227 9.1% 120/1468 8.2% 134/1738 7.7% 175/2138 8.2% 84/1151 7.3% 0.222 
Previous CABG 74/1227 8.8% 69/1468 4.7% 81/1738 4.7% 98/2138 4.6% 54/1151 4.7% 0.170 
Family History 341/1227 27.8% 398/1468 27.1% 483/1738 27.8% 485/2138 22.7% 284/1151 24.7% <0.001* 
VT/VF 1119/1227 91.2% 1350/1468 92.0% 1552/1738 89.3% 1940/2138 90.7% 1030/1151 89.5% <0.05* 
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Table 2. Annual trends in the baseline characteristics of ACS patients presenting with OHCA that were selected to 
undergo any coronary procedure (coronary angiography (CA) ± PCI) over the 5-year period (7,722/9,421) comprised of 
CA alone (1964) and CA+PCI (5758). Data are described as counts (n/N) and percentages (%); where n is the number 
of patients with a characteristic, and N is the total number of patients in that year who underwent CA±PCI (2009 N=1227, 
2010 N=1468, 2011 N=1738, 2012 N=2138, 2013 N=1151). * Indicates unadjusted P<0.05. †Numerical data only 
available from January to July 2013. Abbreviations in order of appearance: AMI acute myocardial infarction, PCI 
percutaneous coronary intervention, CABG coronary artery bypass graft surgery, VT/VF pulseless ventricular 
tachycardia/ventricular fibrillation. 
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Baseline Characteristic 
Procedure Specific Data  
No CA (1) CA alone (2) CA+PCI (3) P Value 
Age over 75 607/1699 35.7% 600/1964 30.5% 1059/5758 18.4% <0.001* 
Sex (Male) 724/1699 42.6% 531/1964 27.0% 4868/5758 84.5% <0.001* 
ST-Elevation 350/1699 20.6% 535/1964 27.2% 5274/5758 91.6% <0.001* 
Previous AMI  470/1699 27.7% 607/1964 30.9% 787/5758 13.7% <0.001* 
Previous Angina  435/1699 25.6% 500/1964 25.5% 754/5758 13.1% <0.001* 
Hypertension  738/1699 43.4% 955/1964 48.6% 2214/5758 38.5% <0.001* 
Hypercholesterolemia  433/1699 25.5% 564/1964 28.7% 1580/5758 27.4% <0.001* 
Peripheral Vascular Disease 76/1699 4.5% 94/1964 4.8% 177/5758 3.1% <0.05* 
Cerebrovascular Disease  195/1699 11.5% 177/1964 9.0% 314/5758 5.5% <0.001* 
Chronic Renal Failure 135/1699 7.9% 139/1964 7.0% 130/5758 2.3% <0.001* 
Heart Failure  148/1699 8.7% 208/1964 10.6% 160/5758 2.8% <0.001* 
Smoker  982/1699 57.8% 1022/1964 52.0% 3906/5758 67.8% <0.001* 
Diabetes  264/1699 15.5% 396/1964 20.2% 649/5758 11.3% <0.001* 
Previous PCI  116/1699 6.8% 184/1964 9.4% 437/5758 7.6% <0.001* 
Previous CABG  168/1699 9.9% 223/1964 11.4% 153/5758 2.7% <0.001* 
Family History  278/1699 16.4% 355/1964 18.1% 1636/5758 28.4% <0.001* 
VT/VF 1322/1699 77.8% 1638/1964 83.4% 5353/5758 93.0% <0.001* 
  
Table 3 A comparison of the baseline characteristics of all patients selected to undergo a coronary 
procedure with those who were not, from the 5-year cohort of ACS patients presenting with OHCA (9,421). 
This is subdivided into groups: (1) no coronary angiogram (CA) (1,191/9,421); (2) coronary angiogram 
(CA) only (1,785/9,421); and (3) coronary angiogram + percutaneous coronary intervention (CA+PCI) 
(6,445/9,421). For clarification see Figure 1. Data are displayed as counts n/N and percentages (%), where 
n is the number of patients documented as having the presence of a baseline characteristic, N is the total 
number of patients in each cohort and % is the proportion, * indicates unadjusted P<0.05. Abbreviations: 
VT/VF pulseless ventricular tachycardia/ventricular fibrillation, CABG coronary artery bypass graft surgery, 
PCI percutaneous coronary intervention. 
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Variable Adjusted Odds Ratio 95% Confidence Interval  P Value 
CA±PCI 
STE 2.51 1.89 to 5.31 <0.05 
Male sex 1.53 1.22 to 1.90 <0.05 
Cerebrovascular Disease 0.70 0.544 to 0.893 <0.05 
Previous coronary artery bypass graft 0.70 0.523 to 0.924 <0.05 
CA+PCI 
VT/VF 2.16 1.29 to 3.63 <0.05 
STE 8.34 7.00 to 9.94 <0.05 
Previous PCI 1.88 1.24 to 2.85 <0.05 
Hypercholesterolemia 1.31 1.04 to 1.66 <0.05 
Smoking history 1.45 1.20 to 1.76 <0.05 
Previous coronary artery bypass graft 0.46 0.35 to 0.61 <0.05 
Heart failure 0.69 0.49 to 0.98 <0.05 
Previous AMI 0.55 0.44 to 0.69 <0.05 
 
 
 
 
 
 
Table 4. Multivariable logistic regression analysis demonstrating significant associations between 
categorical covariates and (i) CA±PCI and (ii) CA+PCI (n=9,421). Abbreviations: STE ST-
elevation on post resuscitation ECG, PCI percutaneous coronary intervention, VT/VF pulseless 
ventricular tachycardia/ventricular fibrillation, AMI acute myocardial infarction. 
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Variable Adjusted Odds Ratio 95% Confidence Interval  P Value 
Predictors of in-hospital mortality 
VT/VF 0.15 0.13 to 0.18 <0.001 
Family History 0.39 0.31 to 0.49 <0.001 
CA+PCI 0.62 0.40 to 0.95 <0.05 
Hypercholesterolemia 0.69 0.59 to 0.81 <0.05 
Smoking history 0.73 0.63 to 0.85 <0.001 
Male sex 0.79 0.70 to 0.89 <0.001 
Chronic renal failure 1.40 1.04 to 1.89 <0.05 
Cerebrovascular disease 1.54 1.25 to 1.90 <0.001 
Age over 75 1.59 1.40 to 1.81 <0.001 
Heart failure 1.59 1.25 to 2.02 <0.001 
Peripheral Vascular disease 1.75 1.31 to 2.33 <0.001 
Diabetes 1.98 1.65 to 2.37 <0.001 
 
 
 
 
  
 
 
Table 5. Multivariable logistic regression analysis demonstrating significant associations between 
categorical covariates and in-hospital mortality (n=9,421). Abbreviations: VT/VF pulseless 
ventricular tachycardia/ventricular fibrillation, AMI acute myocardial infarction. 
 
